AlphaMed Press Awarded CEO Cancer Gold
May 25, 2010 06:03 AM Eastern Daylight Time
CARY, N.C.--(EON: Enhanced Online News)--AlphaMed Press has received CEO Cancer Gold Standard™
accreditation, recognizing the organization’s commitment to taking concrete actions to reduce the cancer risk of its
employees and their families through screenings, early detection, and healthy changes in lifestyle and in the
William C. Weldon, chairman and chief executive officer of Johnson & Johnson, chairs the CEO Roundtable on
Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in
collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit
organizations and professionals. Today, nearly one million and a quarter employees and family members are
benefiting from the vision and leadership of employers who have chosen to become Gold Standard accredited.
“The leadership and commitment to employee health of Gold Standard organizations is exemplary,” said Weldon.
“AlphaMed Press is a premier publisher of internationally recognized scientific journals such as STEM CELLS and
THE ONCOLOGIST and we hope that they will serve as a model for other employers, large and small, for-profit
and not-for-profit, to foster a workplace culture of health and wellness.”
The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and
take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn
Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco
use; encouraging physical activity; promoting healthy diet and nutrition; detecting cancer at its earliest stages; and
providing access to quality care, including participation in clinical trials.
“Medicine teaches us that a team approach is best to prevent and treat cancer,” said Ann Murphy,